Your browser doesn't support javascript.
loading
Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis.
Sinha, Michael S; Freifeld, Clark C; Brownstein, John S; Donneyong, Macarius M; Rausch, Paula; Lappin, Brian M; Zhou, Esther H; Dal Pan, Gerald J; Pawar, Ajinkya M; Hwang, Thomas J; Avorn, Jerry; Kesselheim, Aaron S.
Afiliação
  • Sinha MS; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Freifeld CC; College of Computer and Information Science, Northeastern University, Boston, MA, United States.
  • Brownstein JS; Computational Epidemiology Group, Boston Children's Hospital, Boston, MA, United States.
  • Donneyong MM; Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, OH, United States.
  • Rausch P; Food and Drug Administration, Silver Spring, MD, United States.
  • Lappin BM; Food and Drug Administration, Silver Spring, MD, United States.
  • Zhou EH; Food and Drug Administration, Silver Spring, MD, United States.
  • Dal Pan GJ; Food and Drug Administration, Silver Spring, MD, United States.
  • Pawar AM; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Hwang TJ; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Avorn J; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Kesselheim AS; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
JMIR Public Health Surveill ; 4(1): e1, 2018 Jan 05.
Article em En | MEDLINE | ID: mdl-29305342
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Idioma: En Revista: JMIR Public Health Surveill Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Idioma: En Revista: JMIR Public Health Surveill Ano de publicação: 2018 Tipo de documento: Article